Development of a clinical prediction model to guide the selective use of SPECT/CT in papillary thyroid cancer
Liya Zhu, Junik Son, Lu Wang, Haifeng Hou, Byeong-Cheol Ahn · 2026
Read Development of a clinical prediction model to guide the selective use of SPECT/CT in papillary thyroid cancer by Liya Zhu, Junik Son, Lu Wang, Haifeng Hou, Byeong-Cheol Ahn (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13350696.txt.
Description
Liya Zhu and co-authors built in 2026 a clinical forecast model to guide selective use of SPECT/CT after radioiodine whole-body scans in papillary thyroid cancer. Whole-body scanning after radioiodine therapy spots disease only in two dimensions. Adding SPECT/CT lifts accuracy but also adds radiation, time, and cost.
Two hundred sixty-five patients with confirmed papillary thyroid cancer were studied in look-back. All got radioiodine therapy followed by both scans. Patients were sorted by metastasis state. Scan findings were weighed to find predictors of added SPECT/CT gain. The model lets clinicians reserve SPECT/CT for patients most likely to gain from it, sparing others needless radiation and expense with no missed metastases.
Catalog record
| CREATOR | Liya Zhu, Junik Son, Lu Wang, Haifeng Hou, Byeong-Cheol Ahn |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |